Crispr Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.9M | 190k | 46.97 |
| 2024-06-30 | $9.7M | 180k | 54.01 |
| 2024-03-31 | $22M | 324k | 68.16 |
| 2023-12-31 | $32M | 517k | 62.60 |
| 2023-09-30 | $23M | 511k | 45.39 |
| 2023-06-30 | $21M | 373k | 56.14 |
| 2023-03-31 | $21M | 462k | 45.23 |
| 2022-12-31 | $19M | 456k | 40.65 |
| 2022-09-30 | $7.1M | 109k | 65.36 |
| 2022-06-30 | $1.3M | 22k | 60.82 |
| 2022-03-31 | $1.1M | 18k | 62.79 |
| 2021-12-31 | $1.1M | 14k | 75.70 |
| 2021-09-30 | $3.7M | 33k | 111.94 |
| 2021-06-30 | $3.4M | 21k | 161.89 |
| 2021-03-31 | $691k | 5.8k | 119.21 |
| 2020-12-31 | $3.6M | 25k | 145.63 |
| 2020-09-30 | $1.1M | 13k | 83.56 |
| 2020-06-30 | $8.0k | 111 | 72.07 |
| 2020-03-31 | $6.0k | 148 | 40.54 |
| 2019-12-31 | $324k | 5.3k | 60.94 |
| 2019-09-30 | $568k | 14k | 40.93 |
| 2019-06-30 | $459k | 9.7k | 47.17 |
| 2019-03-31 | $528k | 15k | 35.70 |
| 2018-12-31 | $139k | 4.9k | 28.51 |
| 2018-09-30 | $541k | 12k | 44.41 |
| 2018-06-30 | $4.5M | 76k | 58.74 |
| 2018-03-31 | $3.3M | 73k | 45.70 |
| 2017-12-31 | $360k | 15k | 23.53 |
| 2017-09-30 | $211k | 12k | 17.81 |